Illumina has agreed to buy Solexa, which makes genetics analysis systems, for $600 million. Illumina will also provide $50 million for Solexa, which specializes in whole genome sequencing. Illumina says it will maintain Solexa's operations in California and Cambridge, England. Solexa CEO John West becomes a senior vice president in the combined life science research firm.
- here's the report [1] on the buyout from MarketWatch
Links:
[1] http://www.marketwatch.com/news/story/story.aspx?siteid=mktw&guid=%7B3EB8CD4F-4D7C-405F-989D-CBD12B81598F%7D